Department of Surgery, Queen Sirikit National Institute of Child Health, Bangkok, Thailand.
College of Medicine, Rangsit University, Bangkok, Thailand.
J Laparoendosc Adv Surg Tech A. 2024 Jun;34(6):546-553. doi: 10.1089/lap.2023.0335. Epub 2023 Dec 21.
The pediatric choledochal cyst with hepatic duct stenosis occurs postoperative hepatolithiasis, recurrent cholangitis, or pancreatitis. The laparoscopic hepatic ductoplasty can prevent these incidences. To determine the characteristic of hepatic duct stenosis, laparoscopic treatment, and outcomes in systematic review and meta-analysis. We searched the published studies on PubMed, Scopus, and Cochrane Library databases from January 1985 to April 2022 in English language. This protocol was registered to PROSPERO (CRD42022332145). Nine published studies and 412 patients were included. The meta-analysis revealed that the locations were the confluence of the left and right hepatic ducts 43.1%, the left or/and the right hepatic duct 8.3%, and the unclassified location 60.4%. These characteristics included a membranous/septum appearance (44.7%) and a circumferential/relative stenosis (22.7%). The laparoscopic techniques were the wide hilar Roux-en-Y hepaticojejunostomy (28.5%), the excision of membranes/septum (26.5%), and the mixed hepatic ductoplasty (45.0%). The outcomes revealed a minor bile leakage of 3.8% and minimal bleeding. The meta-analysis showed no statistical difference between laparoscopic and open techniques in hepatolithiasis (0% versus 2.00%), anastomosis stricture (4.83% versus 10.00%), and no recurrent cholangitis. There was no conversion rate but showed a trend the prolonged operating time in laparoscopy. Laparoscopic hepatic ductoplasty is safe and effective. The characteristics and location can be feasible laparoscopic procedures. So, hepatic ductoplasty decreases hepatolithiasis, anastomosis stricture, or recurrent cholangitis and may increase minor bile leakage. The systematic review registration was PROSPERO system with CRD42022332145.
小儿胆总管囊肿合并肝内胆管狭窄可导致术后胆石症、复发性胆管炎或胰腺炎。腹腔镜肝管成形术可预防这些并发症。本系统评价和荟萃分析旨在明确肝内胆管狭窄的特征、腹腔镜治疗及结果。我们检索了 1985 年 1 月至 2022 年 4 月在 PubMed、Scopus 和 Cochrane Library 数据库发表的英文文献。本研究方案已在 PROSPERO 系统(CRD42022332145)注册。共纳入 9 项研究,包含 412 例患者。荟萃分析结果显示,狭窄部位位于左右肝管汇合处(43.1%)、左或/和右肝管(8.3%)和未分类部位(60.4%)。狭窄特征包括膜状/隔膜样外观(44.7%)和环状/相对狭窄(22.7%)。腹腔镜技术包括广泛肝门 Roux-en-Y 胆肠吻合术(28.5%)、膜状/隔膜切除(26.5%)和混合肝管成形术(45.0%)。结果显示,轻微胆漏发生率为 3.8%,出血量少。荟萃分析显示,腹腔镜与开腹手术在胆石症(0%比 2.00%)、吻合口狭窄(4.83%比 10.00%)和复发性胆管炎方面无统计学差异。腹腔镜手术虽无中转开腹率,但有延长手术时间的趋势。腹腔镜肝管成形术安全有效。狭窄特征和部位可作为可行的腹腔镜手术指征。肝管成形术可降低胆石症、吻合口狭窄或复发性胆管炎的发生率,并可能增加轻微胆漏。系统评价的注册编号为 PROSPERO 系统(CRD42022332145)。